Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT

NCT02371551

Conditions: Cystic Renal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: Dep. of Nephrology, Hypertension and Clinical Pharmacology, Bern University Hospital Bern, Switzerland

View Trial Details

Completed

Near Infrared Fluorescence Imaging for Bladder Cancer Detection

NCT03058705

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Photodynamic Diagnosis (PDD) in Flexible Cystoscopy

NCT02660190

Conditions: Bladder Cancer, Disease Attributes, Female Urogenital Diseases, +14 more
Locations: Herlev Hospital Herlev, Denmark

Hospitalsenheden Vest Holstebro, Denmark

View Trial Details

Completed

Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer

NCT01840137

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer

NCT01373294

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

NCT02300610

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +20 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Completed

A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]

NCT02302807

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Georgetown University Medical Center Lombardi Cancer Center Washington D.C., District of Columbia, United States

Emory University; Winship Cancer Institute Atlanta, Georgia, United States

Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States

Duke Cancer Center Durham, North Carolina, United States

View all 217 locations

View Trial Details

Completed

Cancer Development In Organ Transplant Recipients

NCT02333279

Conditions: Cardiovascular Diseases, Digestive System Diseases, Digestive System Neoplasms, +29 more
Locations: University Hospital Zurich, Division of Dermatology Zurich, Switzerland

View Trial Details

Completed

Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC

NCT02315755

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Gazi University Ankara, Besevler, Turkey (Türkiye)

Abdurrahman Yurtaslan Onkoloji Hastanesi Ankara, Demetevler, Turkey (Türkiye)

Marmara Üniversitesi Pendik Eğtim Araştırma Hastanesi Pendik, İ̇stanbul, Turkey (Türkiye)

Hacettepe University School of Medicine, Department of Medical Oncology Ankara, Turkey (Türkiye)

View all 19 locations

View Trial Details

Completed

Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.

NCT03744585

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Ipsen Central Contact Paris, France

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions